Cell-based strategies to reconstitute lung function in infants with severe bronchopulmonary dysplasia

Clinics in Perinatology

Volumn 39, Issue 3, 2012, Pages 703-725

  O'Reilly, Megan ^a   Thébaud, Bernard ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bronchopulmonary dysplasia; Cell therapy; Lung injury; Oxygen; Premature birth; Regeneration; Stem cells

Indexed keywords

BLEOMYCIN; ELASTASE; ESCHERICHIA COLI ENDOTOXIN; LIPOPOLYSACCHARIDE; MONOCROTALINE; OVALBUMIN; PAPAIN; TELOMERASE;

AMNION CELL; BONE MARROW; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL MATURATION; CELL POPULATION; CELL REGENERATION; CELL THERAPY; CELL TRANSPLANTATION; CELL TYPE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOLOGY; DISEASE CONTROL; DISEASE SEVERITY; EMPHYSEMA; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENGRAFTMENT; ENZYME ACTIVITY; EXPERIMENTAL MODEL; GESTATIONAL AGE; HOMEOSTASIS; HUMAN; INFANT; LUNG ALVEOLUS EPITHELIUM; LUNG DYSPLASIA; LUNG FUNCTION; LUNG INJURY; MEMBRANE RECONSTITUTION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEWBORN DISEASE; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROXIMAL AIRWAY STEM CELL; PULMONARY HYPERTENSION; RAGWEED; REVIEW; STANDARDIZATION; STEM CELL; TISSUE REPAIR; TRANSLATIONAL RESEARCH; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; VENTILATOR INDUCED LUNG INJURY; VIRUS CELL TRANSFORMATION;

BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; STEM CELL TRANSPLANTATION;

EID: 84865735417     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2012.06.009     Document Type: Review

References (114)

1. Henderson-Smart D.J., Hutchinson J.L., Donoghue D.A., et al. Prenatal predictors of chronic lung disease in very preterm infants. Arch Dis Child Fetal Neonatal Ed 2006, 91:F40-F45.
2. Kinsella J.P., Greenough A., Abman S.H. Bronchopulmonary dysplasia. Lancet 2006, 367:1421-1431.
3. Brostrom E.B., Thunqvist P., Adenfelt G., et al. Obstructive lung disease in children with mild to severe BPD. Respir Med 2010, 104:362-370.
4. Doyle L.W., Faber B., Callanan C., et al. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 2006, 118:108-113.
5. Filippone M., Bonetto G., Corradi M., et al. Evidence of unexpected oxidative stress in airways of adolescents born very preterm. Eur Respir J 2012, [Epub ahead of print].
6. Narang I., Rosenthal M., Cremonesini D., et al. Longitudinal evaluation of airway function 21 years after preterm birth. Am J Respir Crit Care Med 2008, 178:74-80.
7. Smith L.J., van Asperen P.P., McKay K.O., et al. Reduced exercise capacity in children born very preterm. Pediatrics 2008, 122:e287-e293.
8. Cutz E., Chiasson D. Chronic lung disease after premature birth. N Engl J Med 2008, 358:743-745. [author reply: 745-6].
9. Wong P.M., Lees A.N., Louw J., et al. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J 2008, 32:321-328.
10. Yee M., Chess P.R., McGrath-Morrow S.A., et al. Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity. Am J Physiol Lung Cell Mol Physiol 2009, 297:L641-L649.
11. Jobe A.H. The new bronchopulmonary dysplasia. Curr Opin Pediatr 2011, 23:167-172.
12. Blau H.M., Brazelton T.R., Weimann J.M. The evolving concept of a stem cell: entity or function?. Cell 2001, 105:829-841.
13. Stevenson K., McGlynn L., Shiels P.G. Stem cells: outstanding potential and outstanding questions. Scott Med J 2009, 54:35-37.
14. Stripp B.R. Hierarchical organization of lung progenitor cells: is there an adult lung tissue stem cell?. Proc Am Thorac Soc 2008, 5:695-698.
15. Rawlins E.L., Hogan B.L. Epithelial stem cells of the lung: privileged few or opportunities for many?. Development 2006, 133:2455-2465.
16. Giangreco A., Reynolds S.D., Stripp B.R. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 2002, 161:173-182.
17. Kim C.F., Jackson E.L., Woolfenden A.E., et al. Identification of bronchoalveolar stem cells in normal lung and lung cancer. Cell 2005, 121:823-835.
18. McQualter J.L., Yuen K., Williams B., et al. Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc Natl Acad Sci U S A 2010, 107:1414-1419.
19. Rawlins E.L., Clark C.P., Xue Y., et al. The Id2+ distal tip lung epithelium contains individual multipotent embryonic progenitor cells. Development 2009, 136:3741-3745.
20. Kim C.F. Paving the road for lung stem cell biology: bronchoalveolar stem cells and other putative distal lung stem cells. Am J Physiol Lung Cell Mol Physiol 2007, 293:L1092-L1098.
21. Shi W., Xu J., Warburton D. Development, repair and fibrosis: what is common and why it matters. Respirology 2009, 14:656-665.
22. McQualter J.L., Bertoncello I. Concise review: deconstructing the lung to reveal its regenerative potential. Stem Cells 2012, 30(5):811-816.
23. Bertoncello I., McQualter J.L. Endogenous lung stem cells: what is their potential for use in regenerative medicine?. Expert Rev Respir Med 2010, 4:349-362.
24. Liu X., Engelhardt J.F. The glandular stem/progenitor cell niche in airway development and repair. Proc Am Thorac Soc 2008, 5:682-688.
25. Borthwick D.W., Shahbazian M., Krantz Q.T., et al. Evidence for stem-cell niches in the tracheal epithelium. Am J Respir Cell Mol Biol 2001, 24:662-670.
26. Hegab A.E., Ha V.L., Gilbert J.L., et al. Novel stem/progenitor cell population from murine tracheal submucosal gland ducts with multipotent regenerative potential. Stem Cells 2011, 29:1283-1293.
27. Hong K.U., Reynolds S.D., Watkins S., et al. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol 2004, 164:577-588.
28. Giangreco A., Shen H., Reynolds S.D., et al. Molecular phenotype of airway side population cells. Am J Physiol Lung Cell Mol Physiol 2004, 286:L624-L630.
29. Hong K.U., Reynolds S.D., Giangreco A., et al. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol 2001, 24:671-681.
30. Volckaert T., Dill E., Campbell A., et al. Parabronchial smooth muscle constitutes an airway epithelial stem cell niche in the mouse lung after injury. J Clin Invest 2011, 121:4409-4419.
31. Snyder J.C., Teisanu R.M., Stripp B.R. Endogenous lung stem cells and contribution to disease. J Pathol 2009, 217:254-264.
32. Rawlins E.L., Okubo T., Xue Y., et al. The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 2009, 4:525-534.
33. Kumar P.A., Hu Y., Yamamoto Y., et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 2011, 147:525-538.
34. Adamson I.Y., Bowden D.H. The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab Invest 1974, 30:35-42.
35. Brody J.S., Williams M.C. Pulmonary alveolar epithelial cell differentiation. Annu Rev Physiol 1992, 54:351-371.
36. Driscoll B., Buckley S., Bui K.C., et al. Telomerase in alveolar epithelial development and repair. Am J Physiol Lung Cell Mol Physiol 2000, 279:L1191-L1198.
37. Reddy R., Buckley S., Doerken M., et al. Isolation of a putative progenitor subpopulation of alveolar epithelial type 2 cells. Am J Physiol Lung Cell Mol Physiol 2004, 286:L658-L667.
38. Majka S.M., Beutz M.A., Hagen M., et al. Identification of novel resident pulmonary stem cells: form and function of the lung side population. Stem Cells 2005, 23:1073-1081.
39. Martin J., Helm K., Ruegg P., et al. Adult lung side population cells have mesenchymal stem cell potential. Cytotherapy 2008, 10:140-151.
40. Reynolds S.D., Shen H., Reynolds P.R., et al. Molecular and functional properties of lung SP cells. Am J Physiol Lung Cell Mol Physiol 2007, 292:L972-L983.
41. McQualter J.L., Brouard N., Williams B., et al. Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction. Stem Cells 2009, 27:623-633.
42. Herzog E.L., Chai L., Krause D.S. Plasticity of marrow-derived stem cells. Blood 2003, 102:3483-3493.
43. Liebler J.M., Lutzko C., Banfalvi A., et al. Retention of human bone marrow-derived cells in murine lungs following bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2008, 295:L285-L292.
44. Rojas M., Xu J., Woods C.R., et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005, 33:145-152.
45. Kotton D.N., Fine A. Lung stem cells. Cell Tissue Res 2008, 331:145-156.
46. Neuringer I.P., Randell S.H. Stem cells and repair of lung injuries. Respir Res 2004, 5:6.
47. Thebaud B., Abman S.H. Bronchopulmonary dysplasia-where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 2007, 175:978-985.
48. Alvarez D.F., Huang L., King J.A., et al. Lung microvascular endothelium is enriched with progenitor cells that exhibit vasculogenic capacity. Am J Physiol Lung Cell Mol Physiol 2008, 294:L419-L430.
49. Alphonse R.S., Vadivel A., Waszak P., et al. Existence, functional impairment and therapeutic potential of endothelial colony forming cells (ECFCS) in oxygen-induced arrested alveolar growth. Am J Respir Crit Care Med 2011, 183:A1237.
50. Balasubramaniam V., Mervis C.F., Maxey A.M., et al. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1073-L1084.
51. Irwin D., Helm K., Campbell N., et al. Neonatal lung side population cells demonstrate endothelial potential and are altered in response to hyperoxia-induced lung simplification. Am J Physiol Lung Cell Mol Physiol 2007, 293:L941-L951.
52. van Haaften T., Byrne R., Bonnet S., et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 2009, 180:1131-1142.
53. Tropea K.A., Leder E., Aslam M., et al. Bronchoalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2012, 302(9):L829-L837.
54. Popova A.P., Bozyk P.D., Bentley J.K., et al. Isolation of tracheal aspirate mesenchymal stromal cells predicts bronchopulmonary dysplasia. Pediatrics 2010, 126:e1127-e1133.
55. Hennrick K.T., Keeton A.G., Nanua S., et al. Lung cells from neonates show a mesenchymal stem cell phenotype. Am J Respir Crit Care Med 2007, 175:1158-1164.
56. Popova A.P., Bozyk P.D., Goldsmith A.M., et al. Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. Am J Physiol Lung Cell Mol Physiol 2010, 298:L735-L743.
57. Pierro M., Thebaud B. Mesenchymal stem cells in chronic lung disease: culprit or savior?. Am J Physiol Lung Cell Mol Physiol 2010, 298:L732-L734.
58. Baker C.D., Ryan S.L., Ingram D.A., et al. Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia. Am J Respir Crit Care Med 2009, 180:454-461.
59. Borghesi A., Massa M., Campanelli R., et al. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2009, 180:540-546.
60. Paviotti G., Fadini G.P., Boscaro E., et al. Endothelial progenitor cells, bronchopulmonary dysplasia and other short-term outcomes of extremely preterm birth. Early Hum Dev 2011, 87:461-465.
61. Dominici M., Le Blanc K., Mueller I., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
62. Helmy K.Y., Patel S.A., Silverio K., et al. Stem cells and regenerative medicine: accomplishments to date and future promise. Ther Deliv 2010, 1:693-705.
63. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999, 5:309-313.
64. Vats A., Bielby R.C., Tolley N.S., et al. Stem cells. Lancet 2005, 366:592-602.
65. Agostini C. Stem cell therapy for chronic lung diseases: hope and reality. Respir Med 2010, 104(Suppl 1):S86-S91.
66. Blaisdell C.J., Gail D.B., Nabel E.G. National Heart, Lung, and Blood Institute perspective: lung progenitor and stem cells-gaps in knowledge and future opportunities. Stem Cells 2009, 27:2263-2270.
67. Sueblinvong V., Weiss D.J. Stem cells and cell therapy approaches in lung biology and diseases. Transl Res 2010, 156:188-205.
68. Lee J.W., Gupta N., Serikov V., et al. Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther 2009, 9:1259-1270.
69. Weiss D.J., Bertoncello I., Borok Z., et al. Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc 2011, 8:223-272.
70. Aslam M., Baveja R., Liang O.D., et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 2009, 180:1122-1130.
71. Zhang X., Wang H., Shi Y., et al. The role of bone marrow-derived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice. Cell Biol Int 2012, 36(6):589-594.
72. Chang Y.S., Choi S.J., Sung D.K., et al. Intratracheal transplantation of human umbilical cord blood derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats. Cell Transplant 2011, [Epub ahead of print].
73. Chang Y.S., Oh W., Choi S.J., et al. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant 2009, 18:869-886.
74. Balasubramaniam V., Ryan S.L., Seedorf G.J., et al. Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice. Am J Physiol Lung Cell Mol Physiol 2010, 298:L315-L323.
75. Vosdoganes P., Hodges R.J., Lim R., et al. Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep. Am J Obstet Gynecol 2011, 205:156.e26-156.e33.
76. Till J.E., McCulloch E. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961, 14:213-222.
77. Northway W.H., Rosan R.C., Porter D.Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967, 276:357-368.
78. Ling T.Y., Kuo M.D., Li C.L., et al. Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci U S A 2006, 103:9530-9535.
79. Wang D., Morales J.E., Calame D.G., et al. Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther 2010, 18:625-634.
80. Kumamoto M., Nishiwaki T., Matsuo N., et al. Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury. Eur Respir J 2009, 34:740-748.
81. Ortiz L.A., Dutreil M., Fattman C., et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 2007, 104:11002-11007.
82. Moodley Y., Atienza D., Manuelpillai U., et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 2009, 175:303-313.
83. Aguilar S., Scotton C.J., McNulty K., et al. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One 2009, 4:e8013.
84. Murphy S., Lim R., Dickinson H., et al. Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function. Cell Transplant 2011, 20:909-923.
85. Gupta N., Su X., Popov B., et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007, 179:1855-1863.
86. Iyer S.S., Torres-Gonzalez E., Neujahr D.C., et al. Effect of bone marrow-derived mesenchymal stem cells on endotoxin-induced oxidation of plasma cysteine and glutathione in mice. Stem Cells Int 2010, 2010:868076.
87. Xu J., Woods C.R., Mora A.L., et al. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 2007, 293:L131-L141.
88. Yang K.Y., Shih H.C., How C.K., et al. IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in mice. Chest 2011, 140:1243-1253.
89. Mei S.H., McCarter S.D., Deng Y., et al. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007, 4:e269.
90. Xu J., Qu J., Cao L., et al. Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol 2008, 214:472-481.
91. Kim E.S., Chang Y.S., Choi S.J., et al. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice. Respir Res 2011, 12:108.
92. Chien M.H., Bien M.Y., Ku C.C., et al. Systemic human orbital fat-derived stem/stromal cell transplantation ameliorates acute inflammation in lipopolysaccharide-induced acute lung injury. Crit Care Med 2012, 40:1245-1253.
93. Lam C.F., Roan J.N., Lee C.H., et al. Transplantation of endothelial progenitor cells improves pulmonary endothelial function and gas exchange in rabbits with endotoxin-induced acute lung injury. Anesth Analg 2011, 112:620-627.
94. Sun J., Han Z.B., Liao W., et al. Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ Forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti- and pro-inflammatory factors. Cell Physiol Biochem 2011, 27:587-596.
95. Gao X., Chen W., Liang Z., et al. Autotransplantation of circulating endothelial progenitor cells protects against lipopolysaccharide-induced acute lung injury in rabbit. Int Immunopharmacol 2011, 11:1584-1590.
96. Curley G.F., Hayes M., Ansari B., et al. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 2012, 67(6):496-501.
97. Baber S.R., Deng W., Master R.G., et al. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. Am J Physiol Heart Circ Physiol 2007, 292:H1120-H1128.
98. Kanki-Horimoto S., Horimoto H., Mieno S., et al. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation 2006, 114:I181-I185.
99. Raoul W., Wagner-Ballon O., Saber G., et al. Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice. Respir Res 2007, 8:8.
100. Umar S., de Visser Y.P., Steendijk P., et al. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009, 297:H1606-H1616.
101. Zhao Y.D., Courtman D.W., Deng Y., et al. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 2005, 96:442-450.
102. Takahashi M., Nakamura T., Toba T., et al. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng 2004, 10:771-779.
103. Cho K.S., Park H.K., Park H.Y., et al. IFATS collection: immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model. Stem Cells 2009, 27:259-265.
104. Park H.K., Cho K.S., Park H.Y., et al. Adipose-derived stromal cells inhibit allergic airway inflammation in mice. Stem Cells Dev 2010, 19:1811-1818.
105. Firinci F., Karaman M., Baran Y., et al. Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol 2011, 11:1120-1126.
106. Ou-Yang H.F., Huang Y., Hu X.B., et al. Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells. Exp Biol Med (Maywood) 2011, 236:1461-1467.
107. Ionescu L.I., Alphonse R.S., Arizmendi N., et al. Airway delivery of soluble factors from plastic-adherent bone marrow cells prevents murine asthma. Am J Respir Cell Mol Biol 2012, 46:207-216.
108. Nemeth K., Keane-Myers A., Brown J.M., et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci U S A 2010, 107:5652-5657.
109. Huh J.W., Kim S.Y., Lee J.H., et al. Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am J Physiol Lung Cell Mol Physiol 2011, 301:L255-L266.
110. Zhen G., Liu H., Gu N., et al. Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Front Biosci 2008, 13:3415-3422.
111. Shigemura N., Okumura M., Mizuno S., et al. Lung tissue engineering technique with adipose stromal cells improves surgical outcome for pulmonary emphysema. Am J Respir Crit Care Med 2006, 174:1199-1205.
112. Shigemura N., Okumura M., Mizuno S., et al. Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema. Am J Transplant 2006, 6:2592-2600.
113. Katsha A.M., Ohkouchi S., Xin H., et al. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther 2011, 19:196-203.
114. Hegab A.E., Kubo H., Fujino N., et al. Isolation and characterization of murine multipotent lung stem cells. Stem Cells Dev 2010, 19:523-536.